Cerebrolysat solution 1ml #10

Cerebrolysat instruction

Reed more and buy Cerebrolysat on this page

Composition

One ampoule solution Cerebrolysat includes 1 ml of hydrolyzate of the brain of cattle.

Form of issue

    1 milliliter of solution in a glass dark ampoule; 5 ampoules in a contoured package; one or two packages in a box of paper.
    1 milliliter of solution in a glass dark ampoule; 10 ampoules in a contoured package; one or two packages in a box of paper.
    1 milliliter of solution in a glass dark ampoule; 5 ampoules in a pallet; two pallets in a box of paper.
    1 milliliter of solution in a glass dark ampoule; 10 ampoules in a box of paper.

pharmachologic effect

Nootropic action.

Pharmacodynamics and pharmacokinetics

Preparation obtained from brain tissue comprises the amino acid and active peptides through the blood-brain barrier penetrating and coming directly to the nerve cells.
Improves metabolic processes in brain cells, it stimulates the biosynthesis of proteins in neurons, increases resistance to nervous tissue toxicity, hypoglycemia, hypoxia; improves neuroregulation and bioelectroactivity of the brain, strengthens the compensatory reserves of cerebral hemodynamics, which leads to a reduction in the neurological deficit.

Indications for use

    Ischemic stroke.
    As a component of complex therapy of cerebral vascular insufficiency (dyscirculatory encephalopathy).
    Condition after a hemorrhagic stroke.
    Encephalopathy of various genesis.
    Brain trauma (condition after surgical intervention on the brain, craniocerebral injury).
    Myelopathy.
    Radiculopathy of various genesis, including toxic, infectious, traumatic.
    Reduction of concentration in children.
    Neuropathy.
    Cerebral palsy.

Contraindications

    Epileptic status.
    Expressed violations of the kidneys.
    Hypersensitivity to the components of the drug.
    Pregnancy.
It is recommended to use with caution Cerebrolysat during lactation.

Side effects

The introduction of the drug in a number of cases causes irritation, local soreness, flushing. Do not exclude allergic reactions, increased pressure (with concomitant arterial hypertension).

Instructions for use Cerebrolysat (Method and dosage)

Instruction for Cerebrolysat prescribes to administer the drug intramuscularly for 1-5 ml every two days or every day. The course of therapy is 20 injections. After 3-6 months after the end of the first course, you can repeat the treatment with Cerebrolysat again with the agreement of your doctor.
When treating in neuropediatric practice, it is recommended to use 1-2 ml (but not more than 1 ml per 10 kg of weight) of the drug for two weeks, with a repeat of the cycle of therapy up to 3 times a year.

Overdose

No reports of overdose cases.

Interaction

Simultaneous use with antidepressants can enhance their effects.

Storage conditions

Keep away from children. Store at a temperature of up to 20 degrees in a dark place.
Shelf life - 3 years.

special instructions

It is necessary to carefully prescribe Cerebrolysat in case of epilepsy or allergic diathesis.

In pregnancy and lactation

The drug is not prescribed during pregnancy, and during lactation it is used only if there are strict indications.

Reviews about Cerebrolysat

Reviews of Cerebrolysat report that patients (especially in the elderly) after using the drug note improvement in memory and other cognitive abilities. A number of patients consider the effectiveness of the drug to be less than that of a foreign analog of similar composition - Cerebrolysin. In any case, it should be remembered that the above reviews are subjective, and the evidence base for nootropic drugs is generally weak.